|
PHF5A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.641200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.026000E-01 |
| Normal-vs-Stage2 |
4.904200E-01 |
| Normal-vs-Stage3 |
9.140100E-02 |
| Normal-vs-Stage4 |
6.119200E-01 |
| Stage1-vs-Stage2 |
6.526200E-01 |
| Stage1-vs-Stage3 |
9.265500E-02 |
| Stage1-vs-Stage4 |
3.643800E-01 |
| Stage2-vs-Stage3 |
4.817800E-01 |
| Stage2-vs-Stage4 |
3.167600E-01 |
| Stage3-vs-Stage4 |
5.028300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.145400E-01 |
| Normal-vs-AfricanAmerican |
2.253800E-02 |
| Normal-vs-Asian |
7.939200E-01 |
| Caucasian-vs-AfricanAmerican |
2.307800E-02 |
| Caucasian-vs-Asian |
9.444400E-01 |
| AfricanAmerican-vs-Asian |
4.294400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.037600E-01 |
| Normal-vs-Female |
9.538800E-01 |
| Male-vs-Female |
2.223200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.322800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.599200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.564600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.602600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.834000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.395600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.315200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.681000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.273600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.807400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.940200E-01 |
| Normal-vs-Grade 2 |
8.975600E-01 |
| Normal-vs-Grade 3 |
1.928190E-01 |
| Normal-vs-Grade 4 |
4.873800E-01 |
| Grade 1-vs-Grade 2 |
4.597800E-01 |
| Grade 1-vs-Grade 3 |
2.774000E-01 |
| Grade 1-vs-Grade 4 |
4.273000E-01 |
| Grade 2-vs-Grade 3 |
1.313790E-01 |
| Grade 2-vs-Grade 4 |
5.001200E-01 |
| Grade 3-vs-Grade 4 |
8.102600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.204050E-01 |
| Normal-vs-ccB subtype |
6.221300E-03 |
| ccA subtype-vs-ccB subtype |
1.5084000004606E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.778800E-01 |
| Normal-vs-N1 |
9.462600E-01 |
| N0-vs-N1 |
8.593200E-01 |
|
|
